The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -14,322 | -2 | N/A | N/A |
| Depreciation Amortization | 3,238 | N/A | N/A | N/A |
| Income taxes - deferred | -1,344 | N/A | N/A | N/A |
| Accounts receivable | -6,763 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,758 | N/A | N/A | N/A |
| Other Working Capital | 992 | 2 | N/A | N/A |
| Other Operating Activity | 14,949 | 0 | 0 | 0 |
| Operating Cash Flow | $508 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,194 | N/A | N/A | N/A |
| Net Acquisitions | -150 | N/A | N/A | N/A |
| Other Investing Activity | -7,500 | 0 | 0 | 0 |
| Investing Cash Flow | $-8,844 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 12,493 | N/A | N/A | N/A |
| Debt Repayment | -312 | N/A | N/A | N/A |
| Common Stock Issued | 50 | 25 | N/A | N/A |
| Other Financing Activity | -343 | 0 | 0 | 0 |
| Financing Cash Flow | $11,888 | $25 | $N/A | $N/A |
| Beginning Cash Position | 2,446 | N/A | N/A | N/A |
| End Cash Position | 5,998 | 25 | N/A | N/A |
| Net Cash Flow | $3,552 | $25 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 508 | N/A | N/A | N/A |
| Capital Expenditure | -1,194 | N/A | N/A | N/A |
| Free Cash Flow | -686 | 0 | 0 | 0 |